Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells
- PMID: 16280046
- PMCID: PMC1410764
- DOI: 10.1186/bcr1329
Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells
Abstract
Introduction: The metastatic progression of cancer is a direct result of the disregulation of numerous cellular signaling pathways, including those associated with adhesion, migration, and invasion. Members of the Rac family of small GTPases are known to act as regulators of actin cytoskeletal structures and strongly influence the cellular processes of integrin-mediated adhesion and migration. Even though hyperactivated Rac proteins have been shown to influence metastatic processes, these proteins have never been directly linked to metastatic progression.
Methods: To investigate a role for Rac and Cdc42 in metastatic breast cancer cell invasion and migration, relative endogenous Rac or Cdc42 activity was determined in a panel of metastatic variants of the MDA-MB-435 metastatic human breast cancer cell line using a p21-binding domain-PAK pull down assay. To investigate the migratory and invasive potential of the Rac isoforms in human breast cancer, namely Rac1 and the subsequently cloned Rac3, we stably expressed either dominant active Rac1 or dominant active Rac3 into the least metastatic cell variant. Dominant negative Rac1 or dominant negative Rac3 were stably expressed in the most metastatic cell variant. Cell lines expressing mutant Rac1 or Rac3 were analyzed using in vitro adhesion, migration and invasion assays.
Results: We show that increased activation of Rac proteins directly correlates with increasing metastatic potential in a panel of cell variants derived from a single metastatic breast cancer cell line (MDA-MB-435). The same correlation could not be found with activated Cdc42. Expression of a dominant active Rac1 or a dominant active Rac3 resulted in a more invasive and motile phenotype. Moreover, expression of either dominant negative Rac1 or dominant negative Rac3 into the most metastatic cell variant resulted in decreased invasive and motile properties.
Conclusion: This study correlates endogenous Rac activity with high metastatic potential and implicates Rac in the regulation of cell migration and invasion in metastatic breast cancer cells. Taken together, these results suggest a role for both the Rac1 and Rac3 GTPases in human breast cancer progression.
Figures






Similar articles
-
Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines.BMC Cancer. 2013 Feb 6;13:63. doi: 10.1186/1471-2407-13-63. BMC Cancer. 2013. PMID: 23388133 Free PMC article.
-
RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.Oncotarget. 2017 Jan 10;8(2):3072-3103. doi: 10.18632/oncotarget.13618. Oncotarget. 2017. PMID: 27902969 Free PMC article.
-
Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion.Oncogene. 2005 Nov 24;24(53):7821-9. doi: 10.1038/sj.onc.1208909. Oncogene. 2005. PMID: 16027728
-
The Rac3 GTPase in Neuronal Development, Neurodevelopmental Disorders, and Cancer.Cells. 2019 Sep 11;8(9):1063. doi: 10.3390/cells8091063. Cells. 2019. PMID: 31514269 Free PMC article. Review.
-
The role of Rho GTPases' substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study.Biosci Rep. 2020 Jul 31;40(7):BSR20200407. doi: 10.1042/BSR20200407. Biosci Rep. 2020. PMID: 32578854 Free PMC article. Review.
Cited by
-
TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway.Front Oncol. 2019 Jul 9;9:617. doi: 10.3389/fonc.2019.00617. eCollection 2019. Front Oncol. 2019. PMID: 31338333 Free PMC article.
-
Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.Med Oncol. 2013 Dec;30(4):689. doi: 10.1007/s12032-013-0689-2. Epub 2013 Sep 12. Med Oncol. 2013. PMID: 24026656
-
[Effects of arsenic trioxide on migration, invasion and apoptosis of hepatocellular carcinoma HepG2 cells].Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020 Feb 25;37(1):105-111. doi: 10.7507/1001-5515.201907044. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020. PMID: 32096383 Free PMC article. Chinese.
-
RAC3 is a pro-migratory co-activator of ERα.Oncogene. 2011 Apr 28;30(17):1984-94. doi: 10.1038/onc.2010.583. Epub 2011 Jan 10. Oncogene. 2011. PMID: 21217774 Free PMC article.
-
Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42.Cancer Res Commun. 2022 Dec;2(12):1711-1726. doi: 10.1158/2767-9764.crc-22-0303. Epub 2022 Dec 29. Cancer Res Commun. 2022. PMID: 36861094 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous